Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.RU |
First Approval Date01 Jan 2001 |
Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.RU |
First Approval Date01 Jan 1998 |
100 Clinical Results associated with Immapharma LLC
0 Patents (Medical) associated with Immapharma LLC
100 Deals associated with Immapharma LLC
100 Translational Medicine associated with Immapharma LLC